A novel, immortal, and multipotent human neural stem cell line generating functional neurons and oligodendrocytes

Lidia De Filippis, Giuseppe Lamorte, Evan Y. Snyder, Antonio Malgaroli, Angelo L. Vescovi

Research output: Contribution to journalArticle

Abstract

The discovery and study of neural stem cells have revolutionized our understanding of the neurogenetic process, and their inherent ability to adopt expansive growth behavior in vitro is of paramount importance for the development of novel therapeutics based on neural cell replacement. Recent advances in high-throughput assays for drug development and gene discovery dictate the need for rapid, reproducible, long-term expansion of human neural stem cells (hNSCs). In this view, the complement of wild-type cell lines currently available is insufficient. Here we report the establishment of a stable human neural stem cell line (immortalized human NSCs [IhNSCs]) by v-myc-mediated immortalization of previously derived wild-type hNSCs. These cells demonstrate three- to fourfold faster proliferation than wild-type cells in response to growth factors but retain rather similar properties, including multipotentiality. By molecular biology, biochemistry, immunocytochemistry, fluorescence microscopy, and electrophysiology, we show that upon growth factor removal, IhNSCs completely downregulate v-myc expression, cease proliferation, and differentiate terminally into three major neural lineages: astrocytes, oligodendrocytes, and neurons. The latter are functional, mature cells displaying clear-cut morphological and physiological features of terminally differentiated neurons, encompassing mostly the GABAergic, glutamatergic, and cholinergic phenotypes. Finally, IhNSCs produce bona fide oligodendrocytes in fractions up to 20% of total cell number. This is in contrast to the negligible propensity of hNSCs to generate oligodendroglia reported so far. Thus, we describe an immortalized hNSC line endowed with the properties of normal hNSCs and suitable for developing the novel, reliable assays and reproducible high-throughput gene and drug screening that are essential in both diagnostics and cell therapy studies.

Original languageEnglish
Pages (from-to)2312-2321
Number of pages10
JournalStem Cells
Volume25
Issue number9
DOIs
Publication statusPublished - Sep 2007

Fingerprint

Neural Stem Cells
Oligodendroglia
Neurons
Cell Line
Intercellular Signaling Peptides and Proteins
Preclinical Drug Evaluations
Electrophysiology
Genetic Association Studies
Drug Discovery
Cell- and Tissue-Based Therapy
Fluorescence Microscopy
Astrocytes
Biochemistry
Cholinergic Agents
Molecular Biology
Down-Regulation
Cell Count
Immunohistochemistry
Cell Proliferation
Phenotype

Keywords

  • Neural differentiation
  • Neural stem cell
  • Proliferation
  • Stem cell culture

ASJC Scopus subject areas

  • Cell Biology

Cite this

A novel, immortal, and multipotent human neural stem cell line generating functional neurons and oligodendrocytes. / De Filippis, Lidia; Lamorte, Giuseppe; Snyder, Evan Y.; Malgaroli, Antonio; Vescovi, Angelo L.

In: Stem Cells, Vol. 25, No. 9, 09.2007, p. 2312-2321.

Research output: Contribution to journalArticle

@article{fa5757716e1a40f39cf77353a339688b,
title = "A novel, immortal, and multipotent human neural stem cell line generating functional neurons and oligodendrocytes",
abstract = "The discovery and study of neural stem cells have revolutionized our understanding of the neurogenetic process, and their inherent ability to adopt expansive growth behavior in vitro is of paramount importance for the development of novel therapeutics based on neural cell replacement. Recent advances in high-throughput assays for drug development and gene discovery dictate the need for rapid, reproducible, long-term expansion of human neural stem cells (hNSCs). In this view, the complement of wild-type cell lines currently available is insufficient. Here we report the establishment of a stable human neural stem cell line (immortalized human NSCs [IhNSCs]) by v-myc-mediated immortalization of previously derived wild-type hNSCs. These cells demonstrate three- to fourfold faster proliferation than wild-type cells in response to growth factors but retain rather similar properties, including multipotentiality. By molecular biology, biochemistry, immunocytochemistry, fluorescence microscopy, and electrophysiology, we show that upon growth factor removal, IhNSCs completely downregulate v-myc expression, cease proliferation, and differentiate terminally into three major neural lineages: astrocytes, oligodendrocytes, and neurons. The latter are functional, mature cells displaying clear-cut morphological and physiological features of terminally differentiated neurons, encompassing mostly the GABAergic, glutamatergic, and cholinergic phenotypes. Finally, IhNSCs produce bona fide oligodendrocytes in fractions up to 20{\%} of total cell number. This is in contrast to the negligible propensity of hNSCs to generate oligodendroglia reported so far. Thus, we describe an immortalized hNSC line endowed with the properties of normal hNSCs and suitable for developing the novel, reliable assays and reproducible high-throughput gene and drug screening that are essential in both diagnostics and cell therapy studies.",
keywords = "Neural differentiation, Neural stem cell, Proliferation, Stem cell culture",
author = "{De Filippis}, Lidia and Giuseppe Lamorte and Snyder, {Evan Y.} and Antonio Malgaroli and Vescovi, {Angelo L.}",
year = "2007",
month = "9",
doi = "10.1634/stemcells.2007-0040",
language = "English",
volume = "25",
pages = "2312--2321",
journal = "Stem Cells",
issn = "1066-5099",
publisher = "AlphaMed Press",
number = "9",

}

TY - JOUR

T1 - A novel, immortal, and multipotent human neural stem cell line generating functional neurons and oligodendrocytes

AU - De Filippis, Lidia

AU - Lamorte, Giuseppe

AU - Snyder, Evan Y.

AU - Malgaroli, Antonio

AU - Vescovi, Angelo L.

PY - 2007/9

Y1 - 2007/9

N2 - The discovery and study of neural stem cells have revolutionized our understanding of the neurogenetic process, and their inherent ability to adopt expansive growth behavior in vitro is of paramount importance for the development of novel therapeutics based on neural cell replacement. Recent advances in high-throughput assays for drug development and gene discovery dictate the need for rapid, reproducible, long-term expansion of human neural stem cells (hNSCs). In this view, the complement of wild-type cell lines currently available is insufficient. Here we report the establishment of a stable human neural stem cell line (immortalized human NSCs [IhNSCs]) by v-myc-mediated immortalization of previously derived wild-type hNSCs. These cells demonstrate three- to fourfold faster proliferation than wild-type cells in response to growth factors but retain rather similar properties, including multipotentiality. By molecular biology, biochemistry, immunocytochemistry, fluorescence microscopy, and electrophysiology, we show that upon growth factor removal, IhNSCs completely downregulate v-myc expression, cease proliferation, and differentiate terminally into three major neural lineages: astrocytes, oligodendrocytes, and neurons. The latter are functional, mature cells displaying clear-cut morphological and physiological features of terminally differentiated neurons, encompassing mostly the GABAergic, glutamatergic, and cholinergic phenotypes. Finally, IhNSCs produce bona fide oligodendrocytes in fractions up to 20% of total cell number. This is in contrast to the negligible propensity of hNSCs to generate oligodendroglia reported so far. Thus, we describe an immortalized hNSC line endowed with the properties of normal hNSCs and suitable for developing the novel, reliable assays and reproducible high-throughput gene and drug screening that are essential in both diagnostics and cell therapy studies.

AB - The discovery and study of neural stem cells have revolutionized our understanding of the neurogenetic process, and their inherent ability to adopt expansive growth behavior in vitro is of paramount importance for the development of novel therapeutics based on neural cell replacement. Recent advances in high-throughput assays for drug development and gene discovery dictate the need for rapid, reproducible, long-term expansion of human neural stem cells (hNSCs). In this view, the complement of wild-type cell lines currently available is insufficient. Here we report the establishment of a stable human neural stem cell line (immortalized human NSCs [IhNSCs]) by v-myc-mediated immortalization of previously derived wild-type hNSCs. These cells demonstrate three- to fourfold faster proliferation than wild-type cells in response to growth factors but retain rather similar properties, including multipotentiality. By molecular biology, biochemistry, immunocytochemistry, fluorescence microscopy, and electrophysiology, we show that upon growth factor removal, IhNSCs completely downregulate v-myc expression, cease proliferation, and differentiate terminally into three major neural lineages: astrocytes, oligodendrocytes, and neurons. The latter are functional, mature cells displaying clear-cut morphological and physiological features of terminally differentiated neurons, encompassing mostly the GABAergic, glutamatergic, and cholinergic phenotypes. Finally, IhNSCs produce bona fide oligodendrocytes in fractions up to 20% of total cell number. This is in contrast to the negligible propensity of hNSCs to generate oligodendroglia reported so far. Thus, we describe an immortalized hNSC line endowed with the properties of normal hNSCs and suitable for developing the novel, reliable assays and reproducible high-throughput gene and drug screening that are essential in both diagnostics and cell therapy studies.

KW - Neural differentiation

KW - Neural stem cell

KW - Proliferation

KW - Stem cell culture

UR - http://www.scopus.com/inward/record.url?scp=34748919514&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34748919514&partnerID=8YFLogxK

U2 - 10.1634/stemcells.2007-0040

DO - 10.1634/stemcells.2007-0040

M3 - Article

C2 - 17556596

AN - SCOPUS:34748919514

VL - 25

SP - 2312

EP - 2321

JO - Stem Cells

JF - Stem Cells

SN - 1066-5099

IS - 9

ER -